Home
>
National Drug Code (NDC)
>
Stavudine
Stavudine - 0378-5042-05 - (stavudine)
Drug Information of Stavudine
| Product NDC: | 0378-5042 |
| Proprietary Name: | Stavudine |
| Non Proprietary Name: | stavudine |
| Active Ingredient(s): | 30 mg/1 & nbsp; stavudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Stavudine
| Product NDC: | 0378-5042 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079069 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120210 |
Package Information of Stavudine
| Package NDC: | 0378-5042-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5042-05) |
NDC Information of Stavudine
| NDC Code | 0378-5042-05 |
| Proprietary Name | Stavudine |
| Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5042-05) |
| Product NDC | 0378-5042 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | stavudine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120210 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | STAVUDINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
